Rating Change
UBS reiterated its Buy rating on Constellium SE (NYSE:CSTM) on October 08, 2026.
UBS reiterated its Buy rating on Constellium SE (NYSE:CSTM) on October 08, 2026.

At publication ·
Constellium SE (NYSE:CSTM) · reiterate
At a glance
UBS reiterated its Buy rating on Constellium SE (NYSE:CSTM) on October 08, 2026.
Constellium SE operates in the Basic Materials sector. The stock currently trades at $25.60 with a market capitalization of $2.6B. The stock has gained 66.5% over the past 52 weeks.
Analyst coverage from UBS provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Constellium SE.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 08, 2026 | Deutsche Bank | Buy | N/A |
| Oct 08, 2026 | UBS | Buy | N/A |
| Sep 18, 2026 | Wells Fargo | Overweight | N/A |
| Jul 30, 2026 | Wells Fargo | Overweight | N/A |
| Jul 09, 2026 | Wells Fargo | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View CSTM Stock Page
A rating of Buy from UBS reflects the analyst's outlook on Constellium SE (NYSE:CSTM). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CSTM forecast page.
Current market data
NYSE · CSTM
$25.60
Up: +$0.17 · +0.66%
Live quote updated
Keep reading